DURATAF 25 mg is a prescription antiviral medicine containing Alafenamide (TAF). It treats chronic hepatitis B virus (HBV) and Human immunodeficiency virus (HIV) infections. It lowers the amount of virus in the body by stopping viral multiplication.
WHAT ARE DURATAF 25 MG TABLETS?
DURATRAF 25 mg is classified as an antiviral medication, specifically a nucleoside reverse transcriptase (NRTI), used to treat chronic hepatitis B virus (HBV) and HIV infections. It is used in :
- Chronic hepatitis B virus (HBV) infection
- Human immunodeficiency virus .
Key classification:
- Pharmacological class: Nucleoside /Nucleotide Reverse transcriptase inhibitor (NRTI)
- Therapeutic class: Antiretroviral / antiviral agent
- Active ingredient: Tenofovir alafenamide (25 mg)
- Mechanism of Action: Act as a prodrug that enters cells and converts to its active form. It also inhibits Viral DNA polymerase and causes chain termination , stopping the virus from multiplying.
WHAT ARE THE USES OF DURATAF 25 MG TABLETS?
Uses of DURATAF 25 mg tablets are:
- Approved medical indications
DURATAF 25 mg tablet contains TENOFOVIR ALAFENAMIDE (25 mg) as its active ingredient . it is an antiviral medication used in the treatment of certain approved medical conditions and is also utilized as part of combination regimes for HIV-1 infection. it is used for the treatment of following conditions :
- Chronic Hepatitis B (HBV) : lowers viral replication and viral load in the blood to protect the liver from progressive damage, scarring and failure.
- HIV infection : used alongside other antireviral medications to manage HIV-1 and reduce viral load.
2)Role in managing underlying disease
DURATAF 25 mg contains tenofovir Alafenamide (TAF) and act chronic an antiviral medication human immunodeficiency virus (HIV) infections. It works inside cells to stop viruses from making copies of themselves , which lowers the viral load, protect liver tissue and helps preserves immune function .
How DURATAF 25 mg manages the disease?
- Enzyme Blockade: it stops Viral DNA polymerase or reverse transcription from copying genetic material .
- Chain Termination: it enters the viral DNA chain and stops new virus copies from forming.
- Targeted action: it goes straight into cells to lower the amount of virus in the body safely.
- Use alone or with other medicines , where appropriate
DURATAF 25 mg contains tenofovir alafenamide and is prescribed to treat chronic hepatitis B and HIV. For chronic Hepatitis B, it can often be used alone as a single daily dose. For HIV infection, it must always be used combined with other antiretroviral medicines as part of a complete multi-drug regimen. It must be used with other medicines , taking it alone for HIV can cause the virus to build resistance to treatment.
WHAT ARE THE BENEFITS OF DURATAF 25 MG?
Benefits of DURATAF 25 MG are:
- Therapeutic Benefits
- Reduces viral load : lowers the amount of the Hepatitis B or HIV virus in the blood to very low or undetectable levels .
- Protects liver function: prevents the hepatitis B virus from replicating , which reduces the risk of long-term liver damage, scarring and liver failure.
- Improves immunity : helps control HIV when often used in combination with other antiretroval drugs, allowing ones immune system to work better and lowering the risk of complications .
- Better bone and kidney safety : Delivers the active medicine directly inside cells, providing effective viral suppression while lowering the risk of bone mineral loss and kidney toxicity compared to older formulations like TDF.
- Role in controlling underlying conditions
- Enzyme inhibition: Blocks viral DNA polymerase and reverse transcriptase to stop the virus multiplying inside cells
- Viral load reduction: Decreases the amount of active virus in the bloodstream to minimal or undetectable levels.
- Liver protection: lower the risk of severe long-term complications like cirrhosis and liver failure in chronic hepatitis B patients
- Immune support : helps restore and maintain immune system health when managed alongside other antireotrovials for HIV.
- Expected treatment outcomes
Primary clinical goals
- Viral suppression: lowers blood vessels of hepatitis B or HIV virus by blocking viral replication.
- Liver protection: Reduces inflammation and helps normalize liver function tests over time.
- Improved safety profile: Delivers active medicine efficiently to target cells at a lower dose , protecting bone density and kidney functions.
What to expect during Therapy?
- Consistent routine: Daily use is required to keep the viral load suppressed and prevent drug resistance.
- Regular monitoring: periodic blood work is necessary to track viral levels ,kidney function and liver health.
- Ongoing precautions : The medicine does not stop one from passing the virus to others, so safe practices remain essential .
- Importance of treatment adherence
Strict adherence to ones daily dosing schedule keeps the amount of medicine in the body steady, which stops the virus from multiplying , lowers one viral load, protects the liver and prevent the virus from becoming resistant to drug. Adherence matters because:
- Lowers viral count: consistent levels of the medicine in the body keep viral replication suppressed.
- Stops Drug Resistance: skipping doses gives the virus a chance to mutate, rendering the medication permanently ineffective.
- Protects long-term organ health: continuous adherence lowers the risk of severe complications like cirrhosis , liver failure or immune decline.
- Maintain treatment outcomes: keeping the virus under control preserves ones future therapeutic choices.
CONCLUSION
DURATAF 25 mg is an effective, antiviral for chronic hepatitis B and HIV, providing high efficacy with reduced systematic toxicity and better bone and kidney safety compared to older alternatives. It significantly reduces viral load to protect long-term liver health.
FREQUENTLY ASKED QUESTIONS (FAQs):
QUESTION: WHAT IS DURATAF 25 MG USED FOR?
DURATAF 25mg tablet contains Tenofovir Alafenamide and is an antiviral medicine used to treat chronic hepatitis B virus (HBV) infection. it is also used in combination with other drugs to treat HIV infection. it works by stopping the virus from making copies of itself.
QUESTION: HOW DURTRAF 25 MG WORK?
DURATAF 25 mg contains tenofovir alafenamide, an antiviral medication used to treat chronic hepatitis B and HIV. It works as a prodrug that enters infected cells , turns into its active form , and blocks the enzyme the virus needs to copy its DNA, stopping the virus from multiplying and lowering the viral load.
QUESTION: WHAT ARE THE COMMON SIDE EFFECTS OF DURATAF 25 MG?
Common side effects of DURATAF 25 mg are:
- Headache
- Nausea and vomiting
- Diarrhea
- Fatigue or felling tired
- Stomach or abdominal pain
- Joint pain
- Dizziness
- Rash or itching.
REFRENCES:
1)https://www.1mg.com/drugs/durataf-25mg-tablet-511623?wpsrc=Google+Organic+Search
2) https://m.indiamart.com/proddetail/durataf-tenofovir-alafenamide-25mg-tablet-24154875630.html
